Cor Vasa 2022, 64(Suppl. 4):79-86

The year in cardiovascular medicine 2021: acute cardiovascular care and ischaemic heart disease

Susanna Price1, 2, *, Jason Katz3, Christoph C. Kaufmann4, Kurt Huber4, 5, 6
1 Consultant Cardiologist & Intensivist, Royal Brompton Hospital, London, UK;
2 National Heart & Lung Institute, Imperial College, London, UK;
3 Duke University, Durham, NC, USA;
4 3rd Medical Department, Cardiology and Intensive Care Medicine, Klinik Ottakring (Wilhelminenhospital), Montleartstrasse 37, 1160, Vienna, Austria;
5 Medical School, Sigmund Freud University, Vienna, Austria; and
6 Ludwig Boltzmann Institute for Cardiovascular Research, Vienna, Austria

Received 15 December 2021; accepted 23 December 2021; online publish-ahead-of-print 3 January 2022
Reproduced from: Price S, Katz J, Kaufmann CC, Huber K. The year in cardiovascular medicine 2020: arrhythmias. Eur Heart J. 2022;43:800–806. https://doi.org/10.1093/eurheartj/ehab908, by permission of Oxford University Press on behalf of the European Society of Cardiology

Keywords: Acute cardiac care; Acute coronary syndromes; Ischaemic heart disease; Cardiogenic shock; COVID-19

Received: July 14, 2022; Accepted: July 14, 2022; Published: December 30, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Price S, Katz J, Kaufmann CC, Huber K. The year in cardiovascular medicine 2021: acute cardiovascular care and ischaemic heart disease. Cor Vasa. 2022;64(Suppl. 4):79-86.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Pessoa-Amorim G, Camm CF, Gajendragadkar P, De Maria GL, Arsac C, Laroche C, et al. Admission of patients with STEMI since theoutbreak of the COVID-19 pandemic: a survey by the European Society of Cardiology. Eur Heart J Qual Care Clin Outcomes 2020;6:210-216. Go to original source... Go to PubMed...
    2. Lechner I, Reindl M, Tiller C, Holzknecht M, Troger F, Fink P, et al. Impact of COVID-19 pandemic restrictions on ST-elevation myocardial infarction: a cardiac magnetic resonance imaging study. Eur Heart J 2021;42:ehab621. Go to original source... Go to PubMed...
    3. Tokarek T, Dziewierz A, Malinowski K, Rakowski T, Bartus S, Dudek D, et al. Treatment delay and clinical outcomes in patients with ST-elevation myocardial infarction during the COVID-19 pandemic. Eur Heart J 2021;42(Suppl 1):ehab724.1470. Go to original source...
    4. Kubica-Malgorzata J, Wioleta O, Stolarek M, Kasprzak M, Grzelakowska K, Kryś J, et al. Impact of COVID-19 pandemic on acute heart failure admissions and mortality: a multicentre study (COV-HF-SIRIO 6 study). ESC Heart Fail 2021;doi: 10.1002/ehf2.13680. Go to original source... Go to PubMed...
    5. Satterfield BA, Bhatt DL, Gersh BJ. Cardiac involvement in the long-term implications of COVID-19. Nat Rev Cardiol 2021;doi: 10.1038/s41569-021-00631-3. Go to original source... Go to PubMed...
    6. Kotecha T, Knight DS, Razvi Y, Kumar K, Vimalesvaran K, Thornton G, et al. Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance. Eur Heart J 2021;42:1866-1878. Go to original source... Go to PubMed...
    7. Schlapbach LJ, Andre MC, Grazioli S, Schöbi N, Ritz N, Aebi C, et al. Best practice recommendations for the diagnosis and management of children with pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS; multisystem inflammatory syndrome in children, MIS-C) in Switzerland. Front Pediatr 2021;9:667507. Go to original source... Go to PubMed...
    8. Carter MJ, Shankar-Hari M, Tibby SM. Paediatric inflammatory multisystem syndrome temporally-associated with SARS-CoV-2 infection: an overview. Intensive Care Med 2021;47:90-93. Go to original source... Go to PubMed...
    9. Witberg G, Barda N, Hoss S, Richter I, Wiessman M, Aviv Y, et al. Myocarditis after COVID-19 vaccination in a large health care organization. N Engl J Med 2021;385:2132-2139. Go to original source... Go to PubMed...
    10. Foltran D, Delmas C, Flumian C, De Paoli P, Salvo F, Gautier S, et al. Myocarditis and pericarditis in adolescents after first and second doses of mRNA COVID-19 vaccines. Eur Heart J Qual Care Clin Outcomes 2021;qcab090. https://doi.org/10. 1093/ehjqcco/qcab090. Go to original source... Go to PubMed...
    11. Hwang J, Park SH, Lee SW, Lee SB, Lee MH, Jeong GH, et al. Predictors of mortality in thrombotic thrombocytopenia after adenoviral COVID-19 vaccination: the FAPIC score. Eur Heart J 2021;42:4053-4063. Go to original source... Go to PubMed...
    12. Hartiala JA, Han Y, Jia Q, Hilser JR, Huang P, Gukasyan J, et al. Genome-wide analysis identifies novel susceptibility loci for myocardial infarction. Eur Heart J 2021;42:919-933. Go to original source... Go to PubMed...
    13. Leistner DM, Krankel N, Meteva D, Abdelwahed YS, Seppelt C, Stähli BE, et al. Differential immunological signature at the culprit site distinguishes acute coronary syndrome with intact from acute coronary syndrome with ruptured fibrous cap: results from the prospective translational OPTICO-ACS study. Eur Heart J 2020;41:3549-3560. Go to original source... Go to PubMed...
    14. Kyaw T, Loveland P, Kanellakis P, Cao A, Kallies A, Huang AL et al. Alarmin-activated B cells accelerate murine atherosclerosis after myocardial in- farction via plasma cell-immunoglobulin-dependent mechanisms. Eur Heart J 2021;42:938-947. Go to original source... Go to PubMed...
    15. Adamstein NH, MacFadyen JG, Rose LM, Glynn RJ, Dey AK, Libby P, et al. The neutrophil-lymphocyte ratio and incident atherosclerotic events: analyses from five contemporary randomized trials. Eur Heart J 2021;42:896-903. Go to original source... Go to PubMed...
    16. Figtee GA, Vernon ST, Hadziosmanovic N, Sundström J, Alfredsson J, Arnott C, et al. Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data. Lancet 2021;397:1085-1094. Go to original source... Go to PubMed...
    17. Wereski R, Kimenai DM, Bulgara A, Taggart C, Lowe DJ, Mills NL, et al. Risk factors for type 1 and type 2 myocardial infarction. Eur Heart J 2021;doi: 10.1093/ eurheartj/ehab581. Go to original source... Go to PubMed...
    18. Neumann JT, Weimann J, Sörensen NA, Hartikainen TS, Haller PM, Lehmacher J, et al. A biomarker model to distinguish types of myocardial infarction and injury. J Am Coll Cardiol 2021;78:781-790. Go to original source... Go to PubMed...
    19. Jaffe AS, Lindahl B, Giannitsis E, Mueller C, Cullen L, Hammarsten O, et al. ESC study group on cardiac biomarkers of the Association for Acute CardioVascular Care: a fondfarewell at the retirement of CKMB. Eur Heart J 2021;42:2260-2264. Go to original source... Go to PubMed...
    20. Singh A, Gupta A, DeFilippis EM, Qamar A, Biery DW, Almarzooq Z, et al. Cardiovascular mortality after type 1 and type 2 myocardial infarction in young adults. J Am Coll Cardiol 2020;75:1003-1013. Go to original source... Go to PubMed...
    21. Cho KH, Han X, Ahn JH, Hyun DY, Kim MC, Sim DS, et al. Long-term outcomes of patients with late presentation of ST-segment elevation myocardial infarction. J Am Coll Cardiol 2021;77:1859-1870. Go to original source... Go to PubMed...
    22. Broch K, Anstensrud AK, Woxholt S, Sharma K, Tollefsen IM, Bendz B, et al. Randomized trial of interleukin-6 receptor inhibition in patients with acute ST-segment elevation myocardial infarction. J Am Coll Cardiol 2021;77:1845-1855. Go to original source... Go to PubMed...
    23. Fiolet ATL, Opstal TSJ, Mosterd A, Eikelboom JW Jolly SS, Keech AC, et al. Efficacy and safety of low-dose colchicine in patients with coronary disease: a sys- tematic review and meta-analysis of randomized trials. Eur Heart J 2021;42:2765-2775. Go to original source... Go to PubMed...
    24. Ducrocq G, Gonzalez-Juanatey JR, Puymirat E, Lemesle G, Cachanado M, Durand-Zaleski I, et al. Effect of a restrictive vs liberal blood transfusion strategy on major cardiovascular events among patients with acute myocardial infarction and anemia. JAMA 2021;325:552-560. Go to original source... Go to PubMed...
    25. Stefanini GG, Briguori C, Cao D, Baber U, Sartori S, Zhang Z, et al. Ticagrelor monotherapy in patients with chronic kidney disease undergoing percutaneous coronary intervention: TWILIGHT-CKD. Eur Heart J 2021;42:4683-4693. Go to original source... Go to PubMed...
    26. Escaned J, Cao D, Baber U, Nicolas J, Satori S, Zhank Z, et al. Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary inter- vention: TWILIGHT-HBR. Eur Heart J 2021;42:4624-4634. Go to original source... Go to PubMed...
    27. Valgimigli M, Gragnano F, Branca M, Franzone A, Baber U, Jang Y, et al. P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials. BMJ 2021;373:n1332. Go to original source... Go to PubMed...
    28. Desch S, Freund A, Akin I, Behnes M, Preusch MR, Zelniker TA, et al. Angiography after out-of-hospital cardiac arrest without ST-segment elevation. N Engl J Med 2021;doi: 10.1056/NEJMoa2101909. Go to original source... Go to PubMed...
    29. Yannopoulos D, Bartos J, Raveendran G, Walser E, Connett J, Murray TA, et al. Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricularfibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial. Lancet 2020;396:1807-1816. Go to original source... Go to PubMed...
    30. Dankiewicz J, Cronberg T, Lilja G, Jakobsen JC, Levin H, Ullén S, et al. Hypothermia versus normothermia after out-of-hospital cardiac arrest. N Engl J Med 2021;384:2283-2294. Go to original source... Go to PubMed...
    31. Le May M, Osborne C, Russo J, So D, Chong AY, Dick A, et al. Effect of moderate vs mild therapeutic hypothermia on mortality and neurologic outcomes in comatose survivors of out-of-hospital cardiac arrest: the CAPITAL CHILL randomized clinical trial. JAMA 2021;326:1494-1503. Go to original source... Go to PubMed...
    32. Meyer MAS, Wiberg S, Grand J, Meyer ASP, Obling LER, Frydland M, et al. Treatment effects of interleukin-6 receptor antibodies for modulating the sys- temic inflammatory response after out-of-hospital cardiac arrest (the IMICA trial): a double-blinded, placebo-controlled, single-center, randomized, clinical trial. Circulation 2021;143:1841-1851. Go to original source... Go to PubMed...
    33. Petersen LT, Riddersholm S, Andersen DC, Polcwiartek C, Lee CJ-Y, Lauridsen MD, et al. Temporal trends in patient characteristics, presumed causes, and out- comes following cardiogenic shock between 2005 and 2017: a Danish registry-based cohort study. Eur Heart J Acute Cardiovasc Care 2021;10:1074-1083. Go to original source... Go to PubMed...
    34. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021;42:3599-3726. Go to original source... Go to PubMed...
    35. Arrigo M, Price S, Baran DA, Pöss J, Aissaoui N, Bayes-Genis A, et al. Optimising clinical trials in acute myocardial infarction complicated by cardiogenic shock: a statement from the 2020 Critical Care Clinical Trialists Workshop. Lancet Respir Med 2021;9:1192-1202. Go to original source... Go to PubMed...
    36. Ceglarek U, Schellong P, Rosolowski M, Scholz M, Willenberg A, Kratzsch J, et al. The novel cystatin C, lactate, interleukin-6, and N-terminal pro-B-type natriuretic peptide (CLIP)-based mortality risk score in cardiogenic shock after acute myocardial infarction. Eur Heart J 2021;42:2344-2352. Go to original source... Go to PubMed...
    37. Mathew R, Di Santo P, Jung RG, Marbach JA, Hutson J, Simard T, et al. Milrinone as compared with dobutamine in the treatment of cardiogenic shock. N Engl J Med 2021;385:516-525. Go to original source... Go to PubMed...

    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes